P3 Health Partners
PIII
46 hedge funds and large institutions have $24M invested in P3 Health Partners in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
5% more funds holding
Funds holding: 44 → 46 (+2)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
0.2% less ownership
Funds ownership: 1.29% → 1.09% (-0.2%)
51% less capital invested
Capital invested by funds: $49.5M → $24M (-$25.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.2M |
| 2 |
EL
EMFO LLC
Weston,
Florida
|
+$454K |
| 3 |
BlackRock
New York
|
+$248K |
| 4 |
MGIA
Moneta Group Investment Advisors
St Louis,
Missouri
|
+$136K |
| 5 |
AR
Advisory Research
Chicago,
Illinois
|
+$121K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.85M |
| 2 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$2.69M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$1.13M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$544K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$226K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Allspring Global Investments
Charlotte,
North Carolina
| – | -$8.26K | -90 | Closed |
|
52
Citigroup
New York
| – | -$872 | -9 | Closed |
|
|
NA
53
NewEdge Advisors
New Orleans,
Louisiana
| – | -$184 | -2 | Closed |
|
|
CS
54
Credit Suisse
Zurich,
Switzerland
| – | -$2 | – | – |
|
PIII Hedge Fund Activity: Q1 2023 in Review
46 of the 6,278 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q1 2023, worth a combined $24M — down 51% from $49.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PIII positions and 7 closed out — a net gain of 2 holders — while 14 added to existing stakes and 14 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $1.2M. The largest seller was Fidelity Investments, cutting an estimated $3.85M.
- 46 institutional investors held P3 Health Partners (PIII) as of Q1 2023, up from 44 in Q4 2022.
- Funds reported $24M of P3 Health Partners stock for Q1 2023, down 51% quarter-over-quarter.
- 9 funds opened new P3 Health Partners positions in Q1 2023 and 7 closed out, a net change of +2 holders.
- The largest P3 Health Partners buyer in Q1 2023 was Alyeska Investment Group, an estimated $1.2M added.
- The largest P3 Health Partners seller in Q1 2023 was Fidelity Investments, an estimated $3.85M sold.
Based on aggregated 13F filings for Q1 2023.